KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Change in Receivables: 2010-2025

Historic Change in Receivables for Exelixis (EXEL) over the last 14 years, with Oct 2025 value amounting to $17.4 million.

  • Exelixis' Change in Receivables rose 113.67% to $17.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $40.0 million, marking a year-over-year increase of 90.21%. This contributed to the annual value of $27.9 million for FY2025, which is 23.55% up from last year.
  • According to the latest figures from Q4 2025, Exelixis' Change in Receivables is $17.4 million, which was up 62.06% from $10.7 million recorded in Q3 2025.
  • Exelixis' 5-year Change in Receivables high stood at $156.0 million for Q2 2024, and its period low was -$127.0 million during Q3 2024.
  • For the 3-year period, Exelixis' Change in Receivables averaged around $8.6 million, with its median value being $10.7 million (2025).
  • As far as peak fluctuations go, Exelixis' Change in Receivables plummeted by 27,370.73% in 2023, and later spiked by 18,223.93% in 2024.
  • Over the past 5 years, Exelixis' Change in Receivables (Quarterly) stood at $102.2 million in 2021, then slumped by 99.96% to $41,000 in 2022, then tumbled by 27,370.73% to -$11.2 million in 2023, then crashed by 920.20% to -$127.0 million in 2024, then surged by 113.67% to $17.4 million in 2025.
  • Its Change in Receivables was $17.4 million in Q4 2025, compared to $10.7 million in Q3 2025 and $16.1 million in Q2 2025.